Editor’s Letter
Medical journal publication during global stress
This issue of the GaBI Journal is being published during one of the most turbulent periods in over a century. A deadly pandemic is raging, the global economy is stressed,… Read More »
Latest features in GaBI Journal, 2020, Issue 3
The Commentary in this issue of the GaBI Journal by Dr Elwyn Griffiths discusses the need for more global harmonization of regulatory approaches to biological medicines. Dr Griffiths refers to… Read More »
What to look forward to in GaBI Journal, 2020, Issue 2
This issue of the GaBI Journal is being published as the global coronavirus 2 (SARS-CoV-2) pandemic is expanding rapidly in many areas of the world including in the United States… Read More »
Editor’s introduction to the initial issue of the ninth volume of GaBI Journal
The current coronavirus pandemic raises some important questions relevant to generic and/or biosimilar products. While still unproven, there are some indications that approved antiviral compounds exist which might be able… Read More »
Latest features in GaBI Journal, 2019, Issue 3
Patients, their families and providers are facing increasing pressures related to the rapidly expanding global inequality which affects access to all components of a long, healthy, productive life including water,… Read More »
Unmet potential of Generics and Biosimilars to reduce healthcare costs
The high cost of pharmaceuticals has been gaining increasing attention as a threat to both healthcare systems and patients’ access to care globally. This GaBI issue contains articles focusing on… Read More »
Editor’s introduction to the initial issue of the eighth volume of GaBI Journal
This issue contains important information and manuscripts, but the small number of original papers illustrates the challenge the GaBI Journal (as well as many other legitimate journals) is having attracting… Read More »
Fourth and final issue of GaBI Journal’s seventh volume
Globalization of the world’s economy has clearly created both major advances and ongoing challenges including in the pharmaceutical industry. Naming of pharmaceuticals might seem to be an uninteresting topic to… Read More »
Latest features in GaBI Journal, 2018, Issue 3
This third issue of GaBI Journal in 2018 contains manuscripts which discuss a number of important, post-marketing, ‘real world’ generic and biosimilar medicinal product issues. In a Commentary, Pitts and… Read More »
What to look forward to in GaBI Journal, 2018, Issue 2
The second issue of the 2018 GaBI Journal volume is being published at a time of increasing uncertainty concerning trade, tariffs, regulations as well as international and even inter-ally co-operation.… Read More »